State
73,596 recalls have nationwide distribution and so reach Northern Mariana Islands. 23 additional recalls listed Northern Mariana Islands specifically in their distribution scope.
Of the 23 recalls naming Northern Mariana Islands we have scored against our rubric, 0 (0%) are Critical — deaths or serious injuries reported, or the agency’s own highest classification — and 18 (78%) are Severe.
Which agencies issued them
These figures cover only the 23 recalls whose distribution notice names Northern Mariana Islands specifically. The 73,596 nationwide recalls listed below reach every state, so counting them here would make every state page show the same numbers.
Hino is recalling 2021 NJ8A heavy trucks because incorrect software may cause the anti-lock braking system to deactivate, increasing crash risk.
Time-Cap Labs is recalling Metformin Hydrochloride Extended-Release Tablets because FDA analysis found NDMA impurity above acceptable levels.
Amneal Pharmaceuticals is recalling Metformin Hydrochloride Extended-release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Biota Biosciences is recalling sterile cannabidiol vials because they may not be sterile and were marketed without FDA approval.
BIOTA Biosciences is recalling sterile curcumin vials because the product lacks assurance of sterility and contains unapproved ingredients.
Amneal Pharmaceuticals is recalling Metformin Hydrochloride Extended-Release Tablets, 500 mg, because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Amneal Pharmaceuticals is recalling Metformin Hydrochloride Extended-Release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
Amneal Pharmaceuticals is recalling Metformin Hydrochloride Extended-Release Tablets because FDA analysis detected N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level.
BIOTA Biosciences is recalling sterile Cannabidiol (CBD) vials due to lack of assurance of sterility and marketing without an approved NDA/ANDA.
Porsche is recalling 2020 911 Carrera 4S Coupe vehicles because the front axle differential bracket may not be tightened correctly, potentially causing damage to surrounding components and increasing fire risk.
Suntech Medical is recalling Oscar 2 blood pressure monitors because the display may show an incorrect decimal point for three-digit readings in mmHg.
Zest Anchors LLC is recalling Locator Overdenture Implant Systems because the abutments may be out of specification, potentially causing a gap between the implant and abutment.
Forest River is recalling certain 2020-2021 Vengeance trailers because the fifth-wheel landing legs are not properly spaced, potentially allowing the fifth wheel to slip and puncture the trailer floor, increasing injury risk.
Hocoma AG is recalling 494 Lokomat Pro units because a motor controller failure may cause the body weight support rope to move up or down in an uncontrolled way.
Tosoh Bioscience Inc is recalling 529 AIA-900 Analyzers because the substrate monitoring system may fail to detect empty bottles, leading to erroneous immunoassay test results.
Merge Healthcare is recalling specific versions of Merge Cardio software due to a calculation error that may produce false negative Z-Scores.
Volvo is recalling certain 2018–2021 VNL and VNR buses with incorrect Gross Axle Weight Rating labels on rear drive axles. Overloading could cause wheel hub failure and increase the risk of a crash.
Aurobindo Pharma USA is recalling 1,440 bottles of Clozapine 100mg tablets because a consumer reported finding 50mg tablets in the 100mg bottles.
Boy Scouts of America is recalling Cub Scout activity pins because they contain lead levels exceeding federal safety limits.
Providence Medical Technologies is recalling 208 units of Ally Bone Screws due to a potential dimensional manufacturing error that poses a safety risk to patients.
Crown Laboratories is recalling 62,274 tubes of Nystatin Cream because the product failed potency testing at the 9-month interval.
Alembic Pharmaceuticals is recalling aripiprazole tablets because bottles labeled as 2 mg contained 5 mg tablets. The error affects 19,153 bottles distributed nationwide.
Siemens Healthcare Diagnostics is recalling Atellica CH Chemistry Calibrators due to observed calibration errors in Total and Direct Bilirubin assays.
Crown Laboratories is recalling Nystatin Cream, USP, because the product failed potency testing at the 9-month interval.
Siemens Healthcare Diagnostics is recalling ADVIA Chemistry Calibrator lots 534177 and 534179 due to observed calibration errors in Total and Direct Bilirubin assays.